Abstract
To evaluate the evidence for denosumab for the treatment of bone metastases secondary to solid tumours and, using a network meta-analysis, indirectly compare denosumab with bisphosphonates and best supportive care.
| Original language | English |
|---|---|
| Pages (from-to) | 416-30 |
| Number of pages | 15 |
| Journal | European Journal of Cancer |
| Volume | 49 |
| Issue number | 2 |
| DOIs | |
| Publication status | Published - Jan 2013 |
Keywords
- Antibodies, Monoclonal, Humanized
- Antineoplastic Agents
- Antineoplastic Combined Chemotherapy Protocols
- Bone Neoplasms
- Humans
- Neoplasms
- Survival Analysis